<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="the Editor: Mechanisms of increased morbidity and mortality of SARS-CoV-2" exact="infection" post="in individuals with diabetes: what this means for an"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="COVID-19 resource centre remains active. Dear Sir, A diagnosis of" exact="diabetes" post="has been a key indicator of the severity of"/>
 <result pre="thrust of the literature published to date on COVID-19 and" exact="diabetes" post="has emphasized medications as the lynchpin of glycemic control;"/>
 <result pre="and inflammation [1]. It's an epidemiologic and biologic fact that" exact="acquired" post="disorders of glucose metabolism are mostly preventable [2], and"/>
 <result pre="estimated 3.68% increase in HbA1c over 45â€¯days for individuals with" exact="diabetes" post="during this pandemic [5]. These models highlight the imperative"/>
 <result pre="multifarious mechanisms through which SARS-CoV-2 increases morbidity in people with" exact="diabetes" post="shows us that the relationship is complex, and is"/>
 <result pre="presented in recent literature that may explain why people with" exact="diabetes" post="fare worse with COVID-19 than those without. Some of"/>
 <result pre="to this virus. Together, they highlight the multi-system impact of" exact="hyperglycemia" post="and metabolic dysfunction on the body's readiness to face"/>
 <result pre="hyperglycemia and metabolic dysfunction on the body's readiness to face" exact="infectious disease." post="In a 2011 study looking at 21 patients with"/>
 <result pre="disease. In a 2011 study looking at 21 patients with" exact="type 2" post="diabetes and 21 healthy volunteers, it was found that"/>
 <result pre="a 2011 study looking at 21 patients with type 2" exact="diabetes" post="and 21 healthy volunteers, it was found that there"/>
 <result pre="immune cells to perform phagocytosis [6]. Promisingly, when patients with" exact="diabetes" post="underwent intensive 5â€¯day interventions to improve their blood glucose"/>
 <result pre="glucose control under monitored conditions, phagocytosis ability improved [6]. Both" exact="diabetes" post="[7] and even short bouts of hyperglycemia [8] can"/>
 <result pre="conditions, phagocytosis ability improved [6]. Both diabetes [7] and even" exact="short" post="bouts of hyperglycemia [8] can acutely alter immune cells'"/>
 <result pre="improved [6]. Both diabetes [7] and even short bouts of" exact="hyperglycemia" post="[8] can acutely alter immune cells' ability to function"/>
 <result pre="phagocytosis. What's more, high glucose levels may prevent a normal" exact="respiratory" post="burst, the process by which immune cells kill pathogens"/>
 <result pre="information in mind, it seems sensible to focus on minimizing" exact="hyperglycemia" post="in order to enhance our immune cells' ability to"/>
 <result pre="to enhance our immune cells' ability to function properly. Both" exact="diabetes" post="and obesity can lead to a pro-inflammatory state in"/>
 <result pre="enhance our immune cells' ability to function properly. Both diabetes" exact="and obesity" post="can lead to a pro-inflammatory state in the body,"/>
 <result pre="our immune cells' ability to function properly. Both diabetes and" exact="obesity" post="can lead to a pro-inflammatory state in the body,"/>
 <result pre="found to be elevated in the patients that show severe" exact="disease" post="in COVID-19 [11,12], and are associated with increased disease"/>
 <result pre="severe disease in COVID-19 [11,12], and are associated with increased" exact="disease" post="severity [13]. Monoclonal antibody IL-6 inhibitors (normally used in"/>
 <result pre="disease severity [13]. Monoclonal antibody IL-6 inhibitors (normally used in" exact="autoimmune diseases" post="like rheumatoid arthritis) are being tested as therapeutics to"/>
 <result pre="IL-6 are, at baseline, more active in the setting of" exact="diabetes" post="and obesity, and it has been posited that infection"/>
 <result pre="are, at baseline, more active in the setting of diabetes" exact="and obesity," post="and it has been posited that infection with SARS-CoV-2"/>
 <result pre="of diabetes and obesity, and it has been posited that" exact="infection" post="with SARS-CoV-2 may serve to amplify an already primed"/>
 <result pre="are decreased in concentration in the blood of people with" exact="diabetes" post="who have COVID-19, and there is a higher proportion"/>
 <result pre="helper T cells in patients with severe COVID-19 [15]. In" exact="short" post="COVID-19 generates an uncoordinated and aggressive immune response, specifically"/>
 <result pre="intense damage to organs. The baseline pro-inflammatory state found in" exact="diabetes" post="and obesity may serve to exacerbate this. A theorized"/>
 <result pre="damage to organs. The baseline pro-inflammatory state found in diabetes" exact="and obesity" post="may serve to exacerbate this. A theorized potential link"/>
 <result pre="to organs. The baseline pro-inflammatory state found in diabetes and" exact="obesity" post="may serve to exacerbate this. A theorized potential link"/>
 <result pre="may serve to exacerbate this. A theorized potential link between" exact="diabetes" post="and COVID-19 mortality lay in hemoglobin [16]. Because of"/>
 <result pre="hemoglobin [16]. Because of higher circulating glucose levels, patients with" exact="diabetes" post="will have a higher percentage of glycated hemoglobin. SARS-CoV-2"/>
 <result pre="death and intense inflammation in the lungs. Because patients with" exact="diabetes" post="and older people have more glycated hemoglobin, they may"/>
 <result pre="is expressed in lung tissue, cardiac tissue, endothelial cells of" exact="blood vessels," post="the kidney, intestinal cells, hepatocytes, and pancreas cells [4],"/>
 <result pre="(ARBs), all of which are frequently taken by individuals with" exact="diabetes" post="[4]. Aside from medications potentially increasing risk of COVID-19"/>
 <result pre="its infectivity by expediting entry, fusion, duplication, and release in" exact="respiratory" post="cells. Elevated plasmin(ogen) and furin levels are a common"/>
 <result pre="by expediting entry, fusion, duplication, and release in respiratory cells." exact="Elevated" post="plasmin(ogen) and furin levels are a common feature in"/>
 <result pre="absorbed into the cell. In short, proteases normally elevated in" exact="diabetes" post="may be facilitating viral entry into human cells [4]."/>
 <result pre="In short, proteases normally elevated in diabetes may be facilitating" exact="viral" post="entry into human cells [4]. It is known that"/>
 <result pre="process of exposing lung cells to elevated glucose significantly increased" exact="viral infection" post="and replication [19]. Together, this suggests that high blood"/>
 <result pre="of exposing lung cells to elevated glucose significantly increased viral" exact="infection" post="and replication [19]. Together, this suggests that high blood"/>
 <result pre="although this has not been fully established in COVID-19. Furthermore," exact="diabetes" post="is associated with structural changes to lung tissue including"/>
 <result pre="diabetes is associated with structural changes to lung tissue including" exact="collapse" post="of portions of the lung and altered permeability of"/>
 <result pre="of portions of the lung and altered permeability of the" exact="blood vessels" post="in the lung [19]. This impact of diabetes on"/>
 <result pre="the blood vessels in the lung [19]. This impact of" exact="diabetes" post="on lung physiology and structure, in conjunction with the"/>
 <result pre="one of the most important contributors to fatality by compounding" exact="lung inflammation" post="[20]. Additionally, exposure to this trace-gas also has been"/>
 <result pre="to this trace-gas also has been linked to development of" exact="diabetes" post="and many other chronic diseases, and is a potent"/>
 <result pre="has been linked to development of diabetes and many other" exact="chronic" post="diseases, and is a potent driver of cytokine release"/>
 <result pre="a role in quelling the underlying pro-inflammatory state that characterizes" exact="metabolic disease" post="and COVID-19 associated cytokine storms, however more research needs"/>
 <result pre="role in quelling the underlying pro-inflammatory state that characterizes metabolic" exact="disease" post="and COVID-19 associated cytokine storms, however more research needs"/>
 <result pre="industrial chemicals, are also strongly implicated in the pathogenesis of" exact="metabolic syndrome;" post="promoting â€œclean living,â€� toxin-avoidant strategies for patients as simple"/>
 <result pre="as simple as emphasizing organic foods, home air purification, and" exact="non-toxic" post="home supplies could be considered, although the clinical utility"/>
 <result pre="considered, although the clinical utility of these measures in the" exact="acute" post="setting is unknown [21]. It is not just diabetes"/>
 <result pre="the acute setting is unknown [21]. It is not just" exact="diabetes" post="that is making COVID-19 more deadly; it's also possible"/>
 <result pre="COVID-19 more deadly; it's also possible that COVID-19 is making" exact="diabetes" post="worse [11]. It is known that SARS-CoV-2 can infect"/>
 <result pre="and resultant impairment in beta-cell insulin secretion could worsen preexisting" exact="diabetes" post="or even predispose to new cases of diabetes in"/>
 <result pre="worsen preexisting diabetes or even predispose to new cases of" exact="diabetes" post="in non-diabetic subjects. This could make hyperglycemia worse in"/>
 <result pre="new cases of diabetes in non-diabetic subjects. This could make" exact="hyperglycemia" post="worse in the short term (and thus lead to"/>
 <result pre="in non-diabetic subjects. This could make hyperglycemia worse in the" exact="short" post="term (and thus lead to a more severe COVID-19"/>
 <result pre="short term (and thus lead to a more severe COVID-19" exact="disease" post="course), and also trigger the emergence of increased rates"/>
 <result pre="course), and also trigger the emergence of increased rates of" exact="autoimmune" post="diabetes, whereby the body coordinates an immune response to"/>
 <result pre="immune response to the damaged pancreas, with physiology akin to" exact="type 1" post="diabetes. Given this complexity, it is clear that a"/>
 <result pre="future. It is important to remember that influenza and other" exact="bacterial" post="and viral illnesses also discriminate against people with diabetes,"/>
 <result pre="is important to remember that influenza and other bacterial and" exact="viral" post="illnesses also discriminate against people with diabetes, with these"/>
 <result pre="likely to need hospitalization during influenza epidemics than people without" exact="diabetes" post="[22]. We must commit to evidence based dietary and"/>
 <result pre="shown to be highly effective (some studies showing reversal of" exact="diabetes" post="in as little as 10â€¯weeks of coaching and nutritional"/>
 <result pre="toxin exposure [27] all play a role in management of" exact="metabolic disease," post="and yet have been largely missing from existing literature"/>
 <result pre="have been largely missing from existing literature on management of" exact="diabetes" post="in the setting of COVID-19. Importantly, the standard Western"/>
 <result pre="appears to be compounded in patients with COVID-19 who have" exact="diabetes" post="and obesity, and must be a central focus included"/>
 <result pre="to be compounded in patients with COVID-19 who have diabetes" exact="and obesity," post="and must be a central focus included in any"/>
 <result pre="Wang, et al. recently put forth â€œFive Noâ€� rules for" exact="diabetes" post="management during COVID-19 which included â€œno going out, no"/>
 <result pre="out, no gatherings, no sedentariness, no stop on medications, no" exact="anxiety" post="[29].â€� What is starkly missing is the clear, simple,"/>
 <result pre="ultrarefined carbohydrates, both of which are known drivers of postprandial" exact="hyperglycemia" post="and inflammation. As a medical community, we must not"/>
 <result pre="COVID-19 tragedy being that we reverse the tide of the" exact="American" post="chronic disease epidemic. If there's anything this COVID-19 pandemic"/>
 <result pre="tragedy being that we reverse the tide of the American" exact="chronic" post="disease epidemic. If there's anything this COVID-19 pandemic has"/>
 <result pre="being that we reverse the tide of the American chronic" exact="disease" post="epidemic. If there's anything this COVID-19 pandemic has demonstrated,"/>
 <result pre="print, 2020 Apr 17]Brain Behav Immun202010.1016/j.bbi.2020.04.040S0889â€&quot;1591(20)30537â€&quot;7 2SteinbrecherA.MorimotoY.HeakS.The preventable proportion of" exact="type 2" post="diabetes by ethnicity: the multiethnic cohortAnn Epidemiol217201152653510.1016/j.annepidem.2011.03.00921497517 3HallbergS.J.McKenzieA.L.WilliamsP.T.Effectiveness and"/>
 <result pre="Apr 17]Brain Behav Immun202010.1016/j.bbi.2020.04.040S0889â€&quot;1591(20)30537â€&quot;7 2SteinbrecherA.MorimotoY.HeakS.The preventable proportion of type 2" exact="diabetes" post="by ethnicity: the multiethnic cohortAnn Epidemiol217201152653510.1016/j.annepidem.2011.03.00921497517 3HallbergS.J.McKenzieA.L.WilliamsP.T.Effectiveness and safety"/>
 <result pre="safety of a novel care model for the management of" exact="type 2" post="diabetes at 1 year: an open-label, non-randomized, controlled study"/>
 <result pre="a novel care model for the management of type 2" exact="diabetes" post="at 1 year: an open-label, non-randomized, controlled study [published"/>
 <result pre="year: an open-label, non-randomized, controlled study [published correction appears in" exact="diabetes" post="Ther. 2018 Mar 5]Diabetes Ther92201858361210.1007/s13300-018-0373-929417495 4Muniyappa R, Gubbi S."/>
 <result pre="Ther92201858361210.1007/s13300-018-0373-929417495 4Muniyappa R, Gubbi S. COVID-19 pandemic, corona viruses, and" exact="diabetes mellitus" post="[published online ahead of print, 2020 Mar 31]. Am"/>
 <result pre="(10.1152/ajpendo.00124.2020). 5GhosalS.SinhaB.MajumderM.MisraA.Estimation of effects of nationwide lockdown for containing coronavirus" exact="infection" post="on worsening of glycosylated haemoglobin and increase in diabetes-related"/>
 <result pre="2020 Apr 10]Diabetes Metab Syndr144202031932310.1016/j.dsx.2020.03.01432298984 6LecubeA.PachÃ³nG.PetrizJ.HernÃ¡ndezC.SimÃ³R.Phagocytic activity is impaired in" exact="type 2" post="diabetes mellitus and increases after metabolic improvementPLoS One682011e2336610.1371/journal.pone.0023366 7MaR.C.W.HoltR.I.G.COVID-19"/>
 <result pre="10]Diabetes Metab Syndr144202031932310.1016/j.dsx.2020.03.01432298984 6LecubeA.PachÃ³nG.PetrizJ.HernÃ¡ndezC.SimÃ³R.Phagocytic activity is impaired in type 2" exact="diabetes mellitus" post="and increases after metabolic improvementPLoS One682011e2336610.1371/journal.pone.0023366 7MaR.C.W.HoltR.I.G.COVID-19 and diabetesDiabet"/>
 <result pre="increases after metabolic improvementPLoS One682011e2336610.1371/journal.pone.0023366 7MaR.C.W.HoltR.I.G.COVID-19 and diabetesDiabet Med375202072372510.1111/dme.1430032242990 8PalR.BhansaliA.COVID-19," exact="diabetes mellitus" post="and ACE2: the conundrum [published online ahead of print,"/>
 <result pre="2020 Mar 29]Diabetes Res Clin Pract162202010813210.1016/j.diabres.2020.10813232234504 9JafarN.EdrissH.NugentK.The effect of short-term" exact="hyperglycemia" post="on the innate immune systemAm J Med Sci3512201620121110.1016/j.amjms.2015.11.01126897277 10HennesseyP.J.BlackC.T.AndrassyR.J.Nonenzymatic"/>
 <result pre="G impairs complement fixationJPEN J Parenter Enteral Nutr1511991606410.1177/0148607191015001602008035 11MaddaloniE.BuzzettiR.Covid-19 and" exact="diabetes" post="mellitus: unveiling the interaction of two pandemics [published online"/>
 <result pre="S, Zhang M, Wang Q, Lu F. Correlation analysis between" exact="disease" post="severity and inflammation-related parameters in patients with COVID-19 pneumonia."/>
 <result pre="Mar 19. Healio Rheumatologyhttps://www.healio.com/rheumatology/rheumatoid-arthritis/news/online/%7B1957db6e-f7a2-4e5d-939e-d4b5964b2dd3%7D/sarilumab-enters-clinical-trial-for-covid-19-spotlighting-key-role-for-il-6 15RyanP.M.CapliceN.M.Is adipose tissue a reservoir for" exact="viral" post="spread, immune activation and cytokine amplification in COVID-19 [published"/>
 <result pre="factor for COVID-19 susceptibilityPhysiol Rev100320201065107510.1152/physrev.00013.202032216698 19HillM.A.MantzorosC.SowersJ.R.Commentary: COVID-19 in patients with" exact="diabetes" post="[published online ahead of print, 2020 Mar 24]Metabolism107202015421710.1016/j.metabol.2020.15421732220611 20OgenY.Assessing"/>
 <result pre="(COVID-19) fatality [published online ahead of print, 2020 Apr 11]Sci" exact="Total" post="Environ726202013860510.1016/j.scitotenv.2020.13860532302812 21YangC.KongA.P.S.CaiZ.ChungA.C.K.Persistent organic pollutants as risk factors for obesity"/>
 <result pre="11]Sci Total Environ726202013860510.1016/j.scitotenv.2020.13860532302812 21YangC.KongA.P.S.CaiZ.ChungA.C.K.Persistent organic pollutants as risk factors for" exact="obesity" post="and diabetesCurr Diab Rep17122017132Published 2017 Nov 2. doi:10.1007/s11892-017-0966-029098478 22CasqueiroJ.CasqueiroJ.AlvesC.Infections"/>
 <result pre="Diab Rep17122017132Published 2017 Nov 2. doi:10.1007/s11892-017-0966-029098478 22CasqueiroJ.CasqueiroJ.AlvesC.Infections in patients with" exact="diabetes" post="mellitus: a review of pathogenesisIndian J Endocrinol Metab16 Suppl"/>
 <result pre="recommendations reduces hemoglobin A1c level, medication use, and weight in" exact="type 2" post="diabetesJMIR Diabetes212017e5Published 2017 Mar 7. doi:10.2196/diabetes.6981 24ColbergS.R.SigalR.J.YardleyJ.E.Physical activity/exercise and"/>
 <result pre="doi:10.2196/diabetes.6981 24ColbergS.R.SigalR.J.YardleyJ.E.Physical activity/exercise and diabetes: a position statement of the" exact="American" post="Diabetes AssociationDiabetes Care391120162065207910.2337/dc16-172827926890 25AroraT.TaheriS.Sleep optimization and diabetes control: a"/>
 <result pre="24ColbergS.R.SigalR.J.YardleyJ.E.Physical activity/exercise and diabetes: a position statement of the American" exact="Diabetes" post="AssociationDiabetes Care391120162065207910.2337/dc16-172827926890 25AroraT.TaheriS.Sleep optimization and diabetes control: a review"/>
 <result pre="statement of the American Diabetes AssociationDiabetes Care391120162065207910.2337/dc16-172827926890 25AroraT.TaheriS.Sleep optimization and" exact="diabetes" post="control: a review of the literatureDiabetes Ther64201542546810.1007/s13300-015-0141-z26537705 26VasanthR.GaneshA.ShankerR.Impact of"/>
 <result pre="a review of the literatureDiabetes Ther64201542546810.1007/s13300-015-0141-z26537705 26VasanthR.GaneshA.ShankerR.Impact of stress on" exact="type 2" post="diabetes mellitus managementPsychiatr Danub29Suppl. 3201741642128953801 27SargisR.M.HeindelJ.J.PadmanabhanV.Interventions to address environmental"/>
 <result pre="of the literatureDiabetes Ther64201542546810.1007/s13300-015-0141-z26537705 26VasanthR.GaneshA.ShankerR.Impact of stress on type 2" exact="diabetes mellitus" post="managementPsychiatr Danub29Suppl. 3201741642128953801 27SargisR.M.HeindelJ.J.PadmanabhanV.Interventions to address environmental metabolism-disrupting chemicals:"/>
 <result pre="4. doi:10.3389/fendo.2019.0003330778334 28ConnaughtonR.M.McMorrowA.M.McGillicuddyF.C.LithanderF.E.RocheH.M.Impact of anti-inflammatory nutrients on obesity-associated metabolic-inflammation from" exact="childhood" post="through to adulthoodProc Nutr Soc752201611512410.1017/S002966511600007026934951 29WangW.LuJ.GuW.ZhangY.LiuJ.NingG.Care for diabetes with"/>
 <result pre="metabolic-inflammation from childhood through to adulthoodProc Nutr Soc752201611512410.1017/S002966511600007026934951 29WangW.LuJ.GuW.ZhangY.LiuJ.NingG.Care for" exact="diabetes" post="with COVID-19: advice from China [published online ahead of"/>
</results>
